Skip to content

Comparing Intravenous and Oral Paracetamol for Cholecystectomy

Comparative Pharmacokinetics of Intravenous and Oral Paracetamol in the Peri-Operative Period of Laparoscopic Cholecystectomy

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00292214
Enrollment
30
Registered
2006-02-15
Start date
2005-10-31
Completion date
2006-10-31
Last updated
2007-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Cholecystectomy

Keywords

paracetamol, acetaminophen, pharmacokinetic, intravenous, oral, analgesia, pain, opioid

Brief summary

To determine the amount of paracetamol in the blood when given in either intravenous or oral forms prior to cholecystectomy. The clinical effectiveness of each form will also be evaluated with pain scores and the use of other pain relief drugs.

Interventions

Sponsors

Melbourne Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Males and females aged 18-75 * Scheduled to have elective laparoscopic cholecystectomy under general anaesthesia

Exclusion criteria

* Inadequate English comprehension (difficult to obtain informed consent and cooperation), and when interpreters are not available. * History of allergy or sensitivity to paracetamol * Administration of oral paracetamol within previous 8 hours * American Society of Anesthesiologists (ASA) grade IV or V, indicating serious cardio-respiratory co-morbidity * Not suitable for protocol anaesthetic technique (eg: history of nausea and vomiting with morphine)

Design outcomes

Primary

MeasureTime frame
Early pharmacokinetics (0-240 minutes) of a single dose of 1g paracetamol in IV and oral formulations

Secondary

MeasureTime frame
Difference in analgesia achieved (15-120 minutes post-operative) with IV and oral paracetamol.

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026